Dr Agarwals Health Care shareholders approve amalgamation scheme

Dr Agarwals Health Care Limited received approval from its equity shareholders for the scheme of amalgamation with Dr Agarwal's Eye Hospital Limited on Thursday, July 02, 2026. The resolution was passed with a requisite majority during a meeting convened by the National Company Law Tribunal (NCLT) at The Music Academy in Chennai. This approval marks a critical step towards the consolidation of the two entities under the provisions of the Companies Act, 2013.

The meeting was chaired by Shri L N Gupta, with Shri Shivam Parashar appointed as the Scrutinizer to oversee the voting process. Facilities were provided for remote e-voting, e-voting at the venue, and voting via polls. The remote e-voting period commenced on June 07, 2026, and concluded on July 01, 2026. The meeting was attended by 47 equity shareholders, fulfilling the requisite quorum of 30 equity shareholders as prescribed by the Hon'ble NCLT. The total number of shareholders as on the record date, June 03, 2026, was 43,122.

Equity Shareholders Voting Results

The combined voting results for the equity shareholders indicated overwhelming support for the amalgamation scheme. A total of 485 members participated, casting 30,40,15,565 valid votes in favor of the resolution. Votes against the resolution totaled 81,138.

Particulars	No of members Voted	No. of valid Votes cast	No of members Voted in Favour	No of Votes cast in Favor	No of Votes cast Against	Percentage of total votes cast
Remote e-voting	468	303855603	438	303774465	30	99.95 %
E-voting at the Meeting	17	159962	17	159962	Nil	0.05 %
Polls	Nil	Nil	-	-	-	Nil
Total	485	304015565	455	303934427	81138	100.00 %

Public Shareholder Voting

The votes cast by public shareholders, excluding the Promoter and Promoter Group, also approved the scheme. A total of 468 members cast 20,15,11,447 votes, with 20,14,30,309 votes in favour and 81,138 votes against.

Scheme Details and Conditions

The scheme of amalgamation involves Dr Agarwal's Eye Hospital Limited as the transferor company and Dr Agarwals Health Care Limited as the transferee company. The resolution authorizes the Board of Directors to take all necessary actions to implement the scheme, subject to the sanction of the Hon'ble NCLT and other regulatory approvals. The scrutinizer's report confirms that the resolution was duly approved on July 02, 2026. The electronic voting data and polling papers will be handed over to Thanikainathan Arumugam, the Company Secretary and Compliance Officer of Dr Agarwals Health Care Limited.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.45%	+1.18%	+3.34%	-4.07%	+16.51%	+19.44%

Dr. Agarwal's Health Care has closed its trading window for all designated persons and their immediate relatives effective June 30, 2026. This closure is implemented to ensure compliance with its Code of Conduct for Prevention of Insider Trading as the company prepares to finalize and publish its unaudited financial results for the quarter ending June 30, 2026.

The restriction applies to dealings in the securities of the company and will remain in effect until the financial results are officially announced. The trading window is scheduled to reopen 48 hours after the Board of Directors approves and declares the unaudited financial results, which cover both standalone and consolidated figures.

Key Dates and Details

The following table outlines the critical timeline regarding the trading window closure and the upcoming financial announcement:

Event	Date / Time
Trading Window Closure	June 30, 2026
Quarter End	June 30, 2026
Window Reopens	48 hours after results announcement

The company stated that the specific details regarding the board meeting to approve the results will be communicated in due course. This procedural step is standard practice to prevent insider trading while sensitive financial information is being finalized.